… ProQR Announces Closing of Underwritten Public Offering of … and CAMBRIDGE, Mass., Sept. 11, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a biopharmaceutical … securities laws of any such state or jurisdiction. About ProQRProQR Therapeutics is dedicated to changing lives …
… ProQR Announces Clearance of IND to Start Clinical Trial of … Mass., Aug. 12, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … Investigational New Drug (IND) application for QR-1123. ProQR plans to start enrolling patients in a Phase 1/2 trial …
… ProQR to Present its Ophthalmology Pipeline at ARVO, … in our ophthalmology pipeline at ARVO”, said Noreen R. Henig, Chief Medical Officer at ProQR. “These programs have many common elements with QR-110 …